Management of hypertriglyceridemia in the diabetic patient - Wikidata - awgldk - TriplyDB

Management of hypertriglyceridemia in the diabetic patient

Management of hypertriglyceridemia in the diabetic patient

http://www.wikidata.org/entity/Q33935729

about

Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?Beneficial Effects of Omega-3 Fatty Acids on Low Density Lipoprotein Particle Size in Patients with Type 2 Diabetes Already under Statin Therapy.Chylomicronaemia--current diagnosis and future therapies.The effect of selective estrogen receptor modulators on type 2 diabetes onset in women: Basic and clinical insights.Bile acid sequestrants and diabetes: introduction and overview to the supplement An LC-MS based untargeted metabolomics study identified novel biomarkers for coronary heart disease.

P2860

Q33776187-5BD1C186-5426-4690-86F8-6FB2C822650A Q36945460-4E79BB00-F899-4792-923B-AD52756B9864 Q38366873-5C52CDE5-1386-44A8-AC26-4EE26C3B1355 Q39129668-616DF01D-FF8A-49E3-A8AE-838C0019AC61 Q42786926-7911B2CF-C8C0-4162-9167-6900B6CC970A Q51135560-945C47BD-1E48-4B9F-8F21-710D6C61431F

P2860

Management of hypertriglyceridemia in the diabetic patient

http://www.wikidata.org/entity/Q33935729

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Management of hypertriglyceridemia in the diabetic patient

@ast

Management of hypertriglyceridemia in the diabetic patient

@en

type

label

Management of hypertriglyceridemia in the diabetic patient

@ast

Management of hypertriglyceridemia in the diabetic patient

@en

prefLabel

Management of hypertriglyceridemia in the diabetic patient

@ast

Management of hypertriglyceridemia in the diabetic patient

@en

P1433

Q33935729-AE4A08DC-3169-4404-ABC2-48B85F4F6730

P1476

Q33935729-1473EB76-9540-4BD4-86E4-04238A0D022F

P2093

Q33935729-6BB12E17-9D09-4F87-8A7B-73FA78ABB405

Q33935729-89CDC9CA-EAF2-43E7-8E1B-3921EF2DB1CF

Q33935729-B155213A-6543-4773-ACDC-D8334D96C6A9

P2860

Q33935729-09A160EC-1BEB-4FE6-80B0-96611FDD8AF5

Q33935729-0A0C4231-A53F-46A9-A220-3FEF573B78D0

Q33935729-1159E911-D455-46E1-89B7-B08BF3CB3CE0

Q33935729-12F0FCD9-15CF-49CD-B512-4230666006D1

Q33935729-18DB6D46-7DBD-4281-AF15-7AE4AEC6526D

Q33935729-1A297DEA-F408-4DF1-A8E3-DB1E33DDD3F5

Q33935729-1D952F8D-80AD-4500-876C-D6D30C185DFE

Q33935729-2FF4D1A6-6C5D-494F-822F-7F54BCFBA409

Q33935729-4B2830B1-7234-4C6E-A4FE-FDB4D73C0417

Q33935729-545E1161-015B-4FCC-849C-26E701B62871

P2888

Q33935729-5DB5D675-0EFA-4010-A17C-215803F6EBC1

P304

Q33935729-6F8876C3-2AF5-45CD-8442-53C7633BEF76

P31

Q33935729-3EB3736F-5469-499E-8E29-794704F9C8E4

Q33935729-E4B8EF3E-190F-44B7-9CE9-A38165291098

P356

Q33935729-4AFD3F05-F40D-422A-BBF4-4A0565233128

P433

Q33935729-2736E574-B811-4B91-84FA-829F145E8F6E

P478

Q33935729-31ED31DD-BD10-4737-8182-721DC27DB6C8

P577

Q33935729-F44404A8-3BF7-49AB-BB80-D197E83A8986

P5875

Q33935729-32B97160-F05F-4FAA-B854-506CFE70FD57

P6179

Q33935729-34B2F8BF-73EB-44BA-B9FF-0825FF890FEF

P698

Q33935729-B0C98175-F0D6-426F-9B35-4377AE0BD288

P921

Q33935729-3A8A0802-FBD1-4A2F-9F07-382C64FF6D26

Q33935729-3F88FE02-A9B1-45E7-B373-DB96FCDF0DCD

Q33935729-649819FF-10DA-41C3-8D27-16EEB30F0809

Q33935729-8A084162-9D1D-48BF-8CDB-AB665EFD2404

Q33935729-D49EBBA6-DAB9-4D6A-ACC4-503FA79C1595

Q33935729-D84A9A74-EAAE-4E57-8E22-F616C030D279

Q33935729-F68B02E0-CDCC-4C45-812D-1DCA5EA41544

P932

Q33935729-A24F85A0-7CCE-4FFA-8ECF-DEB29681CB98

P356

S11892-010-0124-4

P1433

Current diabetes report

P1476

Management of hypertriglyceridemia in the diabetic patient

@en

P2093

Ishwarlal Jialal

http://www.w3.org/2001/XMLSchema#string

Manpreet Kaur

http://www.w3.org/2001/XMLSchema#string

William Amess

http://www.w3.org/2001/XMLSchema#string

P2860

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

Effects of combination lipid therapy in type 2 diabetes mellitus.

Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

Extended-release niacin or ezetimibe and carotid intima-media thickness.

Chylomicronemia syndrome.

Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia.

Clinical practice. Hypertriglyceridemia.

Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

P2888

s11892-010-0124-4

P304

316-320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11892-010-0124-4

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44658372

http://www.w3.org/2001/XMLSchema#string

P6179

1052093699

http://www.w3.org/2001/XMLSchema#string

P698

20532703

http://www.w3.org/2001/XMLSchema#string

P921

hypertriglyceridemia

heterocyclic compound

type-2 diabetes

mechanism of action

maturity-onset diabetes of the young

P932

2890983

http://www.w3.org/2001/XMLSchema#string